Darifenacin Hydrobromide extended Release IP 7.5
Nov 02, 2022
Derifenac 7.5
Darifenacin Hydrobromide extended Release IP 7.5 is used to treat an overactive bladder. By relaxing the muscles in the bladder, Darifenacin Hydrobromide extended Release IP 7.5 improves your ability to control your urination. Darifenacin Hydrobromide extended Release IP 7.5 helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
For more information please contact:
Recent Post
Nateglinide 60 mg: Uses, Benefits, Dosage, and Side Effects Explained
Why Doctors Recommend Ferric Pyrophosphate with Vitamin B12 and Folic Acid
Esomeprazole 20 mg Tablet: Uses, Benefits, Price and Side Effects Explained
Gabapentin 450 mg Sustained Release: Uses in Neuropathy and Seizure Disorders
What Is Glycopyrrolate, Formoterol & Budesonide Inhaler? Complete Guide for COPD Patients
Why Doctors Recommend Bacillus Clausii Spores Suspension for Gut Health
How Brimonidine Tartrate Eye Drops IP 0.2% w/v Help Lower Intraocular Pressure
Dorzolamide and Timolol Eye Drops IP: Effective Treatment for Glaucoma and Ocular Hypertension
Bethanechol Chloride Extended Release 75 mg Tablets: Uses, Dosage, and Side Effects
How Metoprolol 25 mg & Amlodipine 2.5 mg Tablets Help Control Hypertension
